0.3374
0.81%
0.0027
Dopo l'orario di chiusura:
.35
0.0126
+3.73%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché FGEN Giù?
Forum
Previsione
Precedente Chiudi:
$0.3347
Aprire:
$0.3526
Volume 24 ore:
965.09K
Relative Volume:
0.80
Capitalizzazione di mercato:
$33.85M
Reddito:
$147.75M
Utile/perdita netta:
$-284.23M
Rapporto P/E:
-0.0995
EPS:
-3.39
Flusso di cassa netto:
$-317.54M
1 W Prestazione:
-0.35%
1M Prestazione:
-13.82%
6M Prestazione:
-71.88%
1 anno Prestazione:
-40.86%
Fibrogen Inc Stock (FGEN) Company Profile
Nome
Fibrogen Inc
Settore
Industria
Telefono
415-978-1200
Indirizzo
350 BAY STREET, SAN FRANCISCO, CA
Confronta FGEN con altri titoli
Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
---|---|---|---|---|---|---|
FGEN | 0.3374 | 33.85M | 147.75M | -284.23M | -317.54M | -3.39 |
VRTX | 467.01 | 119.87B | 10.63B | -479.80M | -1.35B | 13.33 |
REGN | 762.00 | 83.27B | 13.85B | 4.65B | 3.32B | 35.06 |
ARGX | 567.90 | 33.96B | 1.86B | -40.29M | -1.28B | -4.16 |
ALNY | 232.27 | 30.18B | 2.09B | -332.26M | 16.06M | -4.14 |
BNTX | 101.87 | 24.42B | 3.30B | -501.07M | 1.03B | 11.54 |
Fibrogen Inc Stock (FGEN) Upgrades & Downgrades
Data | Azione | Analista | Modifica della valutazione |
---|---|---|---|
2023-08-08 | Downgrade | BofA Securities | Neutral → Underperform |
2023-06-26 | Downgrade | BofA Securities | Buy → Neutral |
2023-06-26 | Downgrade | Raymond James | Outperform → Mkt Perform |
2023-06-26 | Downgrade | Stifel | Buy → Hold |
2023-06-26 | Downgrade | William Blair | Outperform → Mkt Perform |
2023-06-02 | Aggiornamento | Stifel | Hold → Buy |
2023-01-31 | Aggiornamento | William Blair | Mkt Perform → Outperform |
2023-01-26 | Aggiornamento | Raymond James | Mkt Perform → Outperform |
2023-01-05 | Aggiornamento | BofA Securities | Neutral → Buy |
2021-09-22 | Downgrade | Goldman | Neutral → Sell |
2021-08-20 | Aggiornamento | Raymond James | Underperform → Mkt Perform |
2021-07-16 | Downgrade | BofA Securities | Buy → Neutral |
2021-07-16 | Downgrade | Stifel | Buy → Hold |
2021-04-07 | Downgrade | H.C. Wainwright | Buy → Neutral |
2021-04-07 | Downgrade | Mizuho | Buy → Neutral |
2021-03-31 | Aggiornamento | BofA Securities | Neutral → Buy |
2021-03-02 | Downgrade | Jefferies | Buy → Hold |
2021-02-01 | Iniziato | H.C. Wainwright | Buy |
2020-10-26 | Iniziato | Raymond James | Underperform |
2020-07-10 | Ripresa | Stifel | Buy |
2020-05-01 | Iniziato | Cowen | Market Perform |
2020-04-27 | Iniziato | BofA/Merrill | Neutral |
2019-05-29 | Ripresa | Goldman | Neutral |
2019-05-10 | Downgrade | William Blair | Outperform → Mkt Perform |
2019-04-12 | Iniziato | Piper Jaffray | Neutral |
2019-02-11 | Ripresa | Stifel | Buy |
2018-12-19 | Aggiornamento | Citigroup | Neutral → Buy |
2017-08-08 | Reiterato | Leerink Partners | Outperform |
2017-08-08 | Reiterato | Stifel | Buy |
2017-07-21 | Downgrade | Goldman | Buy → Neutral |
2017-07-11 | Iniziato | Jefferies | Buy |
2016-02-11 | Aggiornamento | Credit Suisse | Neutral → Outperform |
2016-01-21 | Iniziato | Credit Suisse | Neutral |
2015-12-04 | Iniziato | Citigroup | Buy |
2015-09-23 | Iniziato | Lake Street | Hold |
2015-07-29 | Iniziato | Citigroup | Buy |
2015-07-20 | Aggiornamento | Goldman | Neutral → Buy |
2014-12-09 | Iniziato | Stifel | Buy |
Mostra tutto
Fibrogen Inc Borsa (FGEN) Ultime notizie
StockNews.com Begins Coverage on FibroGen (NASDAQ:FGEN) - Defense World
ARMISTICE CAPITAL, LLC Reduces Stake in FibroGen Inc - GuruFocus.com
FibroGen Third Quarter 2024 Earnings: Beats Expectations - Yahoo Finance
FGEN stock touches 52-week low at $0.19 amid market challenges - Investing.com India
FibroGen, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com
FibroGen, Inc. (NASDAQ:FGEN) Q3 2024 Earnings Call Transcript - Insider Monkey
Earnings call: FibroGen reports strong Q3 sales, advances in oncology pipeline - Investing.com UK
FibroGen: Q3 Earnings Snapshot - mySA
FibroGen Inc (FGEN) Q3 2024 Earnings Call Highlights: Strong Rev - GuruFocus.com
FibroGen (FGEN) Reports Q3 Loss, Tops Revenue Estimates - MSN
FibroGen Inc (FGEN) Q3 2024 Earnings Call Highlights: Strong Revenue Growth Amid Cost Reductions By GuruFocus - Investing.com Canada
FibroGen Inc (FGEN) Q3 2024 Earnings Call Highlights: Strong Revenue Growth Amid Cost Reductions - Yahoo Finance
FibroGen Reports Strong Q3 Growth and Future Plans - TipRanks
FibroGen Inc earnings beat by $0.14, revenue topped estimates - Investing.com Australia
FibroGen Inc (FGEN) Q3 2024 Earnings: Revenue Surges to $46.3M, EPS at $(0.17), Exceeding Estimates - GuruFocus.com
FibroGen Reports Third Quarter 2024 Financial Results - GlobeNewswire
FibroGen Q3 Revenue Surges 15% as China Sales Soar; Narrows Net Loss by 73% | FGEN Stock News - StockTitan
FibroGen Inc (FGEN) Is On The Launchpad, Waiting For Long-Term Buyers. - Stocks Register
FibroGen to Report Third Quarter 2024 Financial Results - GlobeNewswire
Metrics That Matter About FibroGen Inc (NASDAQ: FGEN) - Stocks Register
FGEN stock touches 52-week low at $0.3 amid market challenges - Investing.com Australia
Little Excitement Around FibroGen, Inc.'s (NASDAQ:FGEN) Revenues As Shares Take 26% Pounding - Simply Wall St
FibroGen (NASDAQ:FGEN) Coverage Initiated by Analysts at StockNews.com - Defense World
FGEN stock touches 52-week low at $0.3 amid market challenges By Investing.com - Investing.com South Africa
FibroGen (NASDAQ:FGEN) Research Coverage Started at StockNews.com - Defense World
The growth track for FibroGen Inc (FGEN) has changed recently - SETE News
Should investors be concerned about FibroGen Inc (FGEN)? - US Post News
Cubist Systematic Strategies LLC Has $256,000 Stock Holdings in FibroGen, Inc. (NASDAQ:FGEN) - Defense World
Market Watch: FibroGen Inc (FGEN)’s Noteworthy Gain, Closing at 0.36 - The Dwinnex
FibroGen Hits New 52-week High, What's Fuelling The Stock? - RTTNews
Pulmonary Fibrosis Drug Market Size & Analysis By 2024 -2034 -Boehringer Ingelheim, Roche, FibroGen, Inc., Merck & Co., – IndiaPolitics.com - IndiaPolitics.com
Sei Investments Co. Purchases 41,442 Shares of FibroGen, Inc. (NASDAQ:FGEN) - Defense World
Financial Review: FibroGen (NASDAQ:FGEN) and Oncotelic Therapeutics (OTCMKTS:OTLC) - Defense World
FibroGen's US$6.2m Market Cap Fall Books Insider Losses - Simply Wall St
FibroGen Inc [FGEN] Chief Medical Officer makes an insider acquire of 22,123 shares worth 25,884. - Knox Daily
FibroGen Inc (FGEN) Q2 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic Shifts - Yahoo Finance
Investors in cash trouble should check out FibroGen Inc (FGEN) - SETE News
FGEN stock touches 52-week low at $0.33 amid market challenges By Investing.com - Investing.com South Africa
FGEN stock touches 52-week low at $0.33 amid market challenges - Investing.com Australia
A year in review: FibroGen Inc (FGEN)’s performance in the last year - US Post News
Trading Day Triumph: FibroGen Inc (FGEN) Ends at 0.37, a -8.07 Surge/Plunge - The Dwinnex
FibroGen Inc Inc. (FGEN) Price Performance: The Role of Share Buybacks and Stock Splits - The InvestChronicle
Investing in FibroGen Inc (FGEN): What You Must Know - Knox Daily
StockNews.com Initiates Coverage on FibroGen (NASDAQ:FGEN) - Defense World
FibroGen will pay $10M to exit HQ lease in SF’s Mission Bay - The Real Deal
FibroGen Suit Alleging Disclosure Failures Tossed In Del. - Law360
Fibrogen Inc Azioni (FGEN) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):